Glycoprotein Biomarker Panel for Pancreatic Cancer Discovered by Quantitative Proteomics Analysis

  title={Glycoprotein Biomarker Panel
for Pancreatic Cancer
Discovered by Quantitative Proteomics Analysis},
  author={Song Nie and Andy T-F Lo and Jing Wu and Jianhui Zhu and Zhijing Tan and Diane M Simeone and Michelle A. Anderson and Kerby Shedden and Mack T Ruffin and David M. Lubman},
  booktitle={Journal of proteome research},
Pancreatic cancer is a lethal disease where specific early detection biomarkers would be very valuable to improve outcomes in patients. Many previous studies have compared biosamples from pancreatic cancer patients with healthy controls to find potential biomarkers. However, a range of related disease conditions can influence the performance of these putative biomarkers, including pancreatitis and diabetes. In this study, quantitative proteomics methods were applied to discover potential serum… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 26 extracted citations

Glycans and glycoproteins as specific biomarkers for cancer.

Analytical and bioanalytical chemistry • 2017
View 6 Excerpts
Highly Influenced

Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2016
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…